Engineered T Cells for Type 1 Diabetes Move Closer to Clinic

External Author |

For much of the last decade, Dr. David Rawlings, director of Seattle Children’s Research Institute’s Center for Immunity and Immunotherapies, has dreamed of developing a therapy for children with type 1 diabetes that doesn’t involve insulin injections but uses a person’s own immune cells to target and treat the disease.

Read More

Original Article Source Credits: Seattle Children's  ,

Article Written By : LINDSAY KURS

Original Article Posted on : JUNE 8, 2020 

Link to Original Article: